For citations:
Ovchinnikov A.G., Borisov A.A., Zherebchikova K.Yu., Ryabtseva O.Yu., Gvozdeva A.D., Masenko V.P., Ageev F.T., Boytsov S.A. Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study. Russian Journal of Cardiology. 2021;26(1):4304. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4304
Email this article 